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Abstract
Purpose To determine if the common risks for breech presentation at term labor are also eligible in preterm labor.
Methods A Finnish cross-sectional study included 737,788 singleton births (24–42 gestational weeks) during 2004–2014. 
A multivariable logistic regression analysis was used to calculate the risks of breech presentation.
Results The incidence of breech presentation at delivery decreased from 23.5% in pregnancy weeks 24–27 to 2.5% in term 
pregnancies. In gestational weeks 24–27, preterm premature rupture of membranes was associated with breech presentation. 
In 28–31 gestational weeks, breech presentation was associated with maternal pre-eclampsia/hypertension, preterm premature 
rupture of membranes, and fetal birth weight below the tenth percentile. In gestational weeks 32–36, the risks were advanced 
maternal age, nulliparity, previous cesarean section, preterm premature rupture of membranes, oligohydramnios, birth weight 
below the tenth percentile, female sex, and congenital anomaly. In term pregnancies, breech presentation was associated with 
advanced maternal age, nulliparity, maternal hypothyroidism, pre-gestational diabetes, placenta praevia, premature rupture 
of membranes, oligohydramnios, congenital anomaly, female sex, and birth weight below the tenth percentile.
Conclusion Breech presentation in preterm labor is associated with obstetric risk factors compared to cephalic presentation. 
These risks decrease linearly with the gestational age. In moderate to late preterm delivery, breech presentation is a high-
risk state and some obstetric risk factors are yet visible in early preterm delivery. Breech presentation in extremely preterm 
deliveries has, with the exception of preterm premature rupture of membranes, similar clinical risk profiles as in cephalic 
presentation.
Keywords Breech presentation · Risk factor · Preterm delivery · Preterm labor
Abbreviations
ICD-10  International Statistical Classification of 
Diseases and Related Health Problems 10th 
Revision
WHO  World Health Organization; BMI, body mass 
index
PPROM  Preterm premature rupture of membranes
OR  Crude odds ratio
Cl  Confidence interval
aOR  Adjusted odds ratio
PROM  Premature rupture of membranes
Introduction
The prevalence of breech presentation at delivery decreases 
with increasing gestational age. At 28 pregnancy weeks, 
every fifth fetus lies in the breech presentation and in term 
pregnancies, less than 4% of all singleton fetuses are in 
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breech presentation at delivery [1, 2]. Most likely this is due 
to a lack of fetal movements [3] or an incomplete fetal rota-
tion, since the possibility of a spontaneous rotation declines 
with increasing gestational age. Consequently, preterm labor 
itself is often associated with breech presentation at delivery, 
since the fetus was not yet able to rotate [4–9]. This fact 
makes preterm labor as one of the strongest risk factors for 
breech presentation.
Vaginal breech delivery in term pregnancies is not only 
associated with poorer perinatal outcomes compared to 
vaginal delivery with a fetus in cephalic presentation [6, 
10, 11], but also it is debated whether the cause of breech 
presentation itself is a risk for adverse peri- and neonatal 
outcomes [3, 12, 13]. Several fetal and maternal features, 
such as fetal growth restriction, congenital anomaly, oli-
gohydramnios, gestational diabetes, and previous cesarean 
section, are linked to a higher risk of breech presentation at 
term, and, furthermore, are associated with an increased risk 
for adverse perinatal outcomes [3–5, 8, 9, 14–17].
The literature lacks studies on the risk factors of breech 
presentation in preterm pregnancies. It remains unclear 
whether breech presentation at preterm labor is only caused 
by the incomplete fetal rotation, or whether breech presen-
tation in preterm labor is also associated with other obstet-
ric risk factors. Most of the studies reviewing risk factors 
for breech presentation focus on term pregnancies. Our 
hypothesis is that breech presentation in preterm deliveries 
is, besides preterm pregnancy itself, associated with other 
risk factors similar to breech presentation at term. We aim to 
compare the risks of preterm breech presentation to those in 
cephalic presentation by gestational age. Such information 
would be valuable in the risk stratification of breech deliver-
ies by gestational age.
Materials and methods
We conducted a retrospective population-based cross-
sectional study. The population included all the singleton 
preterm and term births, from January 2004 to December 
2014 in Finland. The data were collected from the national 
medical birth register and the hospital discharge register, 
maintained by the National Institute for Health and Welfare. 
All Finnish maternity hospitals are obligated to contribute 
clinical data on births from 22 weeks or birth weight of 
500 g to the register. All newborn infants are examined by a 
pediatrician and given a personal identification number that 
can be traced in the case of perinatal mortality or morbidity. 
The hospital discharge register contains information on all 
surgical procedures and diagnoses (International Statistical 
Classification of Diseases and Related Health Problems 10th 
Revision, ICD-10) in all inpatient care and outpatient care 
in public hospitals.
Authorization to use the data was obtained from the 
National Institute for Health and Welfare as required by the 
national data protection law in Finland (reference number 
THL/652/5.05.00/2017).
The study population included all the women with a sin-
gleton fetus in breech presentation at the time of delivery. 
The control group included all the women with a singleton 
fetus in cephalic presentation at delivery. Other presenta-
tions were excluded from the study (N = 1671) (Fig. 1). 
Singleton fetuses in breech 
or in cephalic presentaon 
2004–2014
N = 737 788
24–27 weeks of 
gestaon
N = 2056 (0.3%)
Breech
N = 483 
(23.5%)
Cephalic
N = 1573
(76.5%)
28–31 weeks of
gestaon
N = 4582 (0.6%)
Breech
N = 705 
(15.4%)
Cephalic
N = 3877 
(84.6%)
32–36 weeks of
gestaon 
N = 26 851 (3.6%)
Breech
N = 1854
(6.9%)
Cephalic
N = 24997 
(93.1%)
≥ 37 weeks of 
gestaon
N = 704 299 (95.5%)
Breech
N = 17 044
(2.4%)
Cephalic
N = 687 255 
(97.6%)
Excluded: other 
presentaons
N = 1671
Fig. 1  Breech presentation for singleton pregnancies during the period of 2004–2014 in Finland
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Gestational age was determined according to early ultra-
sonographic measurement which is routinely performed in 
Finland and it encompasses over 95% of the mothers, or 
if not available, to the last menstrual period. We excluded 
neonates delivered before 24 weeks of gestation and birth 
weight of less than 500 g, because the lower viability 
may have influenced the mode of the delivery or the out-
come. The study population was divided into four catego-
ries according to the World Health Organization (WHO) 
definitions of preterm and term deliveries. WHO defines 
preterm birth as a fetus born alive before 37 completed 
weeks of pregnancy. WHO recommends sub-categories of 
preterm birth, based on gestational age, as extremely pre-
term (less than 28 pregnancy weeks), very preterm (28–32 
pregnancy weeks), and moderate to late preterm (32–37 
pregnancy weeks).
In our study, we assessed four factors that may be asso-
ciated with breech presentation based on prior reports 
[3–5, 14, 17–20]. These factors were: maternal age below 
25 and 35 years or more, smoking, pre-pregnancy body 
mass index (BMI) over 30, and in vitro fertilization. The 
following factors were also analyzed: nulliparity, more 
than three previous deliveries, and history of cesarean sec-
tion. The obstetric risk factors including maternal hypo- or 
hyperthyroidism (ICD-10 E03, E05), gestational diabetes 
(ICD-10 O24.4) and other diabetes treated with insulin 
(ICD-10 O24.0), arterial hypertension or pre-eclampsia 
(ICD-10 O13, O14), and maternal care for (suspected) 
damage to fetus by alcohol or drugs (ICD-10 O35.4, 
O35.5) were assessed in the analysis. The variables that 
were also included in the analysis were: oligohydram-
nios (ICD-10 O41.0), placenta praevia (ICD-10 O44), 
placental abruption (ICD-10 O45), preterm premature 
rupture of membranes (PPROM) (ICD-10 O42), infant 
sex, fetal birth weight below the tenth percentile, fetuses 
with birth weight above the 97th percentile, and fetal con-
genital anomalies as defined in the register of congenital 
malformations.
The babies born in breech presentation from the 
four study groups were compared with the babies born 
Table 1  Unadjusted and adjusted odds ratios for risk factors in singleton extremely preterm 24 + 0 to 27 + 6 weeks of gestational age fetuses in 
breech and in cephalic presentations during 2004–2014 in Finland
BMI body mass index, IVF in vitro fertilization, maternal intoxication, PPROM preterm premature rupture of membranes
24–27 Weeks of gestation Breech (N = 483) Cephalic (N = 1573) P value Odds ratio (95% Cl) Adjusted odds ratio (95% Cl)
Maternal age < 25 17 (3.5%) 37 (2.4%) 0.153 1.51 (0.84–2.71) 1.56 (0.85–2.84)
Maternal age ≥ 35 129 (26.7%) 438 (27.8%) 0.606 0.94 (0.75–1.19) 0.94 (0.73–1.20)
Smoking 77 (15.9%) 251 (16.0%) 0.934 1 (0.76–1.32) 0.98 (0.74–1.30)
Maternal BMI ≥ 25 78 (16.10%) 262 (16.7%) 0.499 0.96 (0.76–1.32) 0.89 (0.62–1.27)
Maternal BMI ≥ 30 33 (6.8%) 104 (6.6%) 0.898 1.04 (0.69–1.55) 1.03 (0.61–1.75)
Nulliparity 221 (45.8%) 727 (46.2%) 0.409 0.98 (0.80–1.20) 0.91 (0.71–1.16)
Parity ≥ 3 66 (13.7%) 220 (14.0%) 0.983 0.97 (0.72–1.31) 1.01 (0.73–1.40)
Maternal hypothyroidism 6 (1.2%) 9 (0.6%) 0.159 2.19 (0.77–6.17) 2.15 (0.74–6.22)
Maternal hyperthyroidism 1 (0.2%) 3 (0.2%) 0.783 1.09 (0.11–10.46) 1.38 (0.14–13.62)
Pre-gestational diabetes treated with 
insulin
2 (0.4%) 6 (0.4%) 0.577 1.09 (0.22–5.40) 1.27 (0.55–2.96)
Gestational diabetes 20 (4.1%) 48 (3.1%) 0.222 1.37 (0.81–2.34) 1.42 (0.81–2.49)
Pre-eclampsia/hypertension 34 (7.0%) 84 (5.3%) 0.083 1.34 (0.89–2.03) 1.46 (0.95–2.24)
Previous cesarean section 64 (13.3%) 232 (14.7%) 0.294 0.88 (0.66–1.19) 0.85 (0.61–1.17)
IVF 17 (3.5%) 64 (4.1%) 0.828 0.86 (0.50–1.48) 0.94 (0.53–1.65)
Maternal care for (suspected) damage to 
fetus by alcohol/drugs
0 (0.0%) 3 (0.2%) 0.971
Placenta praevia 9 (1.9%) 29 (1.8%) 0.981 1.01 (0.48–2.15) 1.01 (0.47–2.18)
Placental abruption 20 (4.1%) 101 (6.4%) 0.040 0.63 (0.39–1.03) 0.59 (0.36–0.98)
PPROM 120 (24.8%) 308 (19.6%) 0.010 1.36 (1.07–1.73) 1. 39 (1.08–1.79)
Oligohydramnios 16 (3.3%) 45 (2.9%) 0.625 1.16 (0.65–2.08) 1.16 (0.64–2.11)
Congenital anomaly 122 (25.3%) 435 (27.7%) 0.242 0.88 (0.70–1.12) 0.87 (0.68–1.10)
Female sex 234 (48.4%) 734 (46.7%) 0.584 1.07 (0.88–1.32) 1.06 (0.86–1.30)
Birthweight < 10th percentile 47 (9.7%) 174 (11.1%) 0.486 0.87 (0.62–1.22) 1.16 (0.76–1.78)
Birthweight > 97th percentile 4 (0.8%) 15 (1.0%) 0.905 0.87 (0.29–2.63) 0.94 (0.30–2.89)
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in cephalic presentation with the equal gestational age, 
according to WHO classification. The calculations were 
performed using SPSS 19. Statistical differences in cat-
egorical variables were evaluated with the Chi-squared 
test or Fisher’s exact test when appropriate. We calculated 
odds ratios (ORs) with corresponding 95% confidence 
intervals (CIs) using binary logistic regression. Each study 
group was separately adjusted, according to gestational 
age at delivery, defined by WHO. The adjustment for the 
risk factors was done by multivariable logistic regression 
model for all variables. Differences were deemed to be 
statistically significant with P value < 0.05.
Results
This analysis includes 737,788 singleton births, from 
these 20,086 were in breech presentation at the time of 
delivery. Out of all deliveries, 33,489 infants were born 
preterm. The prevalence of breech presentation at delivery 
decreased with the increase of the gestational age: 23.5% 
in extremely preterm delivery, 15.4% very preterm deliv-
eries, and 6.7% in moderate to late preterm deliveries. At 
term, the prevalence of breech presentation at delivery 
was 2.5% (Fig. 1).
From all deliveries, 2056 fetuses were born extremely 
preterm (24 + 0 to 27 + 6 gestational weeks). The differ-
ences in the possible risk factors for breech presentation at 
delivery were higher odds of PPROM (aOR 1.39, 95% CI 
1.08–1.79, P = 0.010) and a lower risk of placental abrup-
tion (aOR 0.59, 95% CI 0.36–0.98, P = 0.040). No statis-
tically significant differences were observed for the other 
factors (Table 1, Figs. 1, 2, 3, 4).
The group of very preterm deliveries (28 + 0 to 31 + 6 
gestational weeks) included 4582 singleton newborns. 
Breech presentation at delivery was associated with 
PPROM (aOR 1.61, 95% CI 1.32–1.96, P < 0.001), oli-
gohydramnios (aOR 1.65, 95% CI 1.03–2.64, P = 0.038), 
fetal birth weight below the tenth percentile (aOR 1.57, 
95% CI 1.19–2.08, P = 0.002), and maternal pre-eclampsia 
and arterial hypertension (aOR 1.31, 95% CI 1.04–1.66, 
P = 0.023). Details of risk factors in very preterm breech 
deliveries are described in Table 2. The risk of placenta 
praevia as well as having a birth weight above the 97th 
percentile was lower in pregnancies with fetuses in breech 
rather than in cephalic presentation (Table 2, Figs. 2, 3, 4).
Fig. 2  Prevalence of obstetric 
risk factors for breech presen-
tation compared to cephalic 
by gestational age. PPROM 
preterm premature rupture of 
membranes, PROM premature 
rupture of membranes
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The moderate to late preterm delivery group (32 + 0 
to 36 + 6 gestational weeks) included 26,851 deliveries. 
Breech presentation in moderate to late preterm deliver-
ies was associated with older maternal age (maternal age 
35 years or more aOR 1.24, 95% CI 1.10–1.39, P < 0.001), 
nullipara (aOR 1.43, 95% CI 1.27–1.60, P < 0.001), mater-
nal BMI less than 25 (maternal BMI ≥ 25 aOR 0.75, 95% 
CI 0.62–0.91, P = 0.004), previous cesarean section (aOR 
1.31, 95% CI 1.12–1.53, P < 0.001), female sex (aOR 
1.22, 95% CI 1.11–1.34, P < 0.001), congenital anomaly 
(aOR 1.37, 95% CI 1.22–1.55, P < 0.001), fetal birth 
weight below the tenth percentile (aOR 1.31, 95% CI 
1.10–1.56, P = 0.003), oligohydramnios (aOR 3.60, 95% 
CI 2.63–4.92, P < 0.001), and PPROM (aOR 1.58, 95% 
CI 1.41–1.78, P < 0.001). Breech presentation decreased 
the odds of having a fetus with birth weight above the 
97th percentile (aOR 0.60, 95% CI 0.42–0.85, P = 0.004) 
(Table 3, Figs. 2, 3, 4).
The term and post-term group included 704,299 deliv-
eries, among them 17,044 fetuses in breech presentation. 
The factors associated with breech presentation amongst 
these were: maternal age of 35 years or more (aOR 1.24, 
95% CI 1.19–1.29, P < 0.001), nullipara (aOR 2.46, 
95% CI 2.37–2.55, P < 0.001), maternal BMI less than 
25 (BMI ≥ 25 aOR 0.90, 95% CI 0.85–0.96, P < 0.001), 
maternal hypothyroidism (aOR 1.53, 95% CI 1.28–1.82, 
P < 0.001), pre-gestational diabetes treated with insu-
lin (aOR 1.24, 95% CI 1.00–1.53, P = 0.049), placenta 
praevia (aOR 1.45, 95% CI 1.11–1.91, P = 0.007), pre-
mature rupture of membranes (PROM) (aOR 1.58, 95% 
CI 1.45–1.72, P < 0.001), oligohydramnios (aOR 2.02, 
95% CI 1.83–2.22, P < 0.001), congenital anomaly (aOR 
1.97, 95% CI 1.89–2.06, P < 0.001), female sex (aOR 1.28, 
95% CI 1.24–1.32, P < 0.001), and birth weight below the 
tenth percentile (aOR 1.18, 95% CI 1.12–1.24, P < 0.001) 
Table 4 includes details for risk factors of term and post-
term group (Figs. 2, 3, 4).
Discussion
The main novel finding of our study was that the risk asso-
ciations increase with each gestational age group after 
28 weeks of gestation. With the exception of PPROM, the 
extremely preterm breech deliveries have similar clinical 
risk profiles as in cephalic presentation when matched for 
gestational age. However, as gestation proceeds, the risks 
start to cluster. In moderate to late preterm pregnancies as 
in term pregnancies, the breech presentation is a high-risk 
state being associated with several risk factors: PPROM, 
Fig. 3  Obstetric risk factors 
for breech presentation with 
adjusted odds ratios by gesta-
tional age. PPROM preterm pre-
mature rupture of membranes, 
PROM premature rupture of 
membranes, aOR adjusted odds 
ratio
0
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oligohydramnios, advanced maternal age, nulliparity, pre-
vious cesarean section, fetal birth weight below the tenth 
percentile, female sex, and fetal congenital anomalies. 
These are in line with the findings of previous studies [3, 
5, 7, 8], that associated breech presentation at term with 
obstetric risk factors. The prevalence of breech presen-
tation was negatively correlated with the gestational age 
with a decline from 23.5% in extremely preterm pregnan-
cies to 2.5% at term. The prevalence of breech presentation 
in preterm pregnancies observed in our trial is similar to 
that of comparable studies [1, 2].
In extremely preterm deliveries, PPROM was the only 
risk factor for breech presentation and it stayed as a risk 
for breech presentation through the gestational weeks. This 
finding is comparable to the previous literature suggesting 
that PPROM occurs more often at earlier gestational age in 
pregnancies with the fetus in breech presentation compared 
with cephalic [21, 22]. PPROM might prevent the fetus to 
change into cephalic presentation. Furthermore, Goodman 
and colleagues (2013) reported that in pregnancies with a 
fetus in a presentation other than cephalic had more com-
plications such as oligohydramnios, infections, placental 
abruption, and even stillbirths. In our study, surprisingly, 
placental abruption seemed to have a negative correlation 
with breech presentation among extremely preterm deliver-
ies. This inconsistency between our results and the literature 
might be due to the small number of cases. Many of the 
obstetric complications, for example gestational diabetes, 
late pre-eclampsia, and late intrauterine growth restric-
tion develop during the second or the third trimester of the 
pregnancy which explains partially why the risk factors for 
breech presentation are rarer in extremely preterm deliveries.
In very preterm delivery, breech presentation was asso-
ciated with PPROM, pre-eclampsia, and fetal birth weight 
below the tenth percentile. Fetal growth restriction is a 
known risk factor for breech presentation at term, since it is 
associated with reduced fetal movements due to diminished 
resources [23–25]. Furthermore, fetal growth restriction is 
Cephalic PPROM
24.8%
Breech
23.5%
24-27 gestational weeks
Cephalic
PPROM 
26.7%
Birthweight 
<10th 
percentile
13.2%
Pre-eclampsia/ 
hypertension 
16.2%
Breech
15.4%
28-31 gestational weeks
Cephalic
PPROM 23.6%
Birthweight <10th 
percentile 11.1%
Oligohydramnios 3.0%
Maternal age ≥35 24.3%
Nulliparity 56.5%
Female sex 48.0%
Previous cesarean 
section 13.8%
Congenital anomaly 
19.5%
Breech
6.9%
32-36 gestational weeks
Cephalic
PROM 3.4%
Oligohydramnios 2.7%
Birthweight <10 percentile 
12.6%
Maternal age ≥35 19.4%
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Fig. 4  The determinants of breech presentation by gestational age. PPROM preterm premature rupture of membranes, PROM premature rupture 
of membranes
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known to be the single largest factor for stillbirth and neo-
natal mortality [26–30]. Maternal arterial hypertension dis-
turbs placental function which might cause low birth weight 
[31, 32]. Arterial hypertension and pre-eclampsia increased 
the risk for breech presentation in very preterm births, but 
not in earlier or later preterm pregnancies. This finding may 
be due to the bias that pre-eclampsia is a well-described 
risk factor for PPROM, fetal growth restriction, and preterm 
deliveries which are also independent markers for breech 
presentation itself [4, 5, 31, 33, 34]. The severity of early 
pre-eclampsia might affect the fetal wellbeing, reduce fetal 
movements and growth, which might reduce the spontane-
ous fetal rotation to the cephalic position [35]. In addition, 
the most severe cases might not reach older gestational age 
before the delivery.
The risk factor for breech presentation in moderate to 
late preterm breech delivery was PPROM, oligohydramnios, 
advanced maternal age, nulliparity, previous cesarean sec-
tion, fetal birth weight below the tenth percentile, female 
sex, and fetal congenital anomalies. Oligohydramnios is a 
known significant risk factor for term breech pregnancies 
[25] and it is linked to the reduced fetal movements partly 
due to a restricted intrauterine space [24, 35] and nuchal 
cords [35]. Additionally, oligohydramnios is associated with 
placental dysfunction, which might reduce fetal resources 
and thus has a progressive effect on the fetal movements 
and prevent the fetus from turning into cephalic presenta-
tion [3, 4, 18]. Fetal female sex in moderate to late preterm 
breech pregnancies remained as a risk factor, as identified 
previously for term pregnancies [3–5]. It has been debated 
whether this risk is due to a smaller fetal size or that female 
fetuses tend to move less [9, 20]. The mothers of infants 
born in breech presentation in moderate to late preterm and 
term and post-term pregnancies seemed to be older and had 
an increased risk of having a fetus with a congenital anom-
aly. The advanced maternal age is associated with negative 
effects on vascular health, which may have an influence on 
the developing fetus and increase the incidence of congenital 
anomalies [19, 34, 36]. Furthermore, congenital anomalies 
may have a negative influence on fetal movements [19, 35]. 
Whereas, the low birth weight was found as a risk for breech 
presentation, a birth weight above the 97th percentile was, 
coherently a protective factor for breech presentation in very 
to term and post-term pregnancies.
Table 2  Unadjusted and adjusted odds ratios for risk factors in singleton very preterm 28 + 0 to 31 + 6 weeks of gestational age fetuses in breech 
and in cephalic presentations during 2004–2014 in Finland
BMI body mass index, IVF in vitro fertilization, PPROM preterm premature rupture of membranes
28–31 Weeks of gestation Breech (N = 705) Cephalic (N = 3877) P value Odds ratio (95% Cl) Adjusted odds 
ratio (95% CI)
Maternal age < 25 10 (1.4%) 108 (2.8%)  < 0.001 0.50 (0.26–0.96) 0.57 (0.29–1.10)
Maternal age ≥ 35 182 (25.8%) 954 (24.6%) 0.095 1.07 (0.89–1.28) 0.97 (0.80–1.18)
Smoking 105 (14.9%) 700 (18.1%) 0.064 0.79 (0.64–0.99) 0.81 (0.64–1.01)
Maternal BMI ≥ 25 109 (15.5%) 532 (13.7%) 0.124 1.15 (0.92–1.44) 1.24 (0.94–1.63)
Maternal BMI ≥ 30 33 (4.7%) 207 (5.3%) 0.053 0.87 (0.60–1.27) 0.64 (0.41–1.01)
Nulliparity 323 (45.8%) 1972 (50.9%) 0.121 0.82 (0.70–0.96) 0.86 (0.71–1.04)
Parity ≥ 3 96 (13.6%) 412 (10.6%) 0.202 1.33 (1.04–1.68) 1.19 (0.91–1.54)
Maternal hypothyroidism 8 (1.1%) 35 (0.9%) 0.888 1.26 (0.58–2.73) 1.06 (0.48–2.34)
Maternal hyperthyroidism 3 (0.4%) 6 (0.2%) 0.227 2.76 (0.69–11.05) 2.38 (0.58–9.72)
Pre-gestational diabetes treated with insulin 5 (0.7%) 16 (0.4%) 0.155 1.72 (0.63–4.72) 1.39 (0.88–2.18)
Gestational diabetes 59 (8.4%) 248 (6.4%) 0.086 1.34 (0.99–1.80) 1.31 (0.96–1.79)
Pre-eclampsia/hypertension 114 (16.2%) 514 (13.3%) 0.023 1.26 (1.01–1.57) 1.31 (1.04–1.66)
Previous cesarean section 128 (18.2%) 519 (15.2%) 0.443 1.23 (1.00–1.52) 1.10 (0.86–1.40)
IVF 22 (3.1%) 169 (4.4%) 0.122 0.71 (0.45–1.11) 0.68 (0.41–1.11)
Maternal care for (suspected) damage to 
fetus by alcohol/drugs
0 (0.0%) 9 (0.2%) 0.973
Placenta praevia 9 (1.3%) 133 (3.4%) 0.004 0.36 (0.18–0.72) 0.36 (0.18–0.72)
Placental abruption 32 (4.5%) 232 (6.0%) 0.225 0.75 (0.51–1.09) 0.79 (0.54–1.16)
PPROM 188 (26.7%) 764 (19.7%) < 0.001 1.48 (1.23–1.78) 1.61 (1.32–1.96)
Oligohydramnios 26 (3.7%) 73 (1.9%) 0.038 2.00 (1.27–3.15) 1.65 (1.03–2.64)
Congenital anomaly 183 (26.0%) 946 (24.4%) 0.453 1.09 (0.90–1.31) 1.08 (0.89–1.30)
Female sex 315 (44.7%) 1739 (44.9%) 0.924 0.99 (0.84–1.17) 0.99 (0.84–1.17)
Birthweight < 10th percentile 93 (13.2%) 348 (9.0%) 0.002 1.54 (1.21–1.97) 1.57 (1.19–2.08)
Birthweight > 97th percentile 8 (1.1%) 97 (2.5%) 0.022 0.45 (0.22–0.92) 0.42 (0.20–0.89)
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We found that in term pregnancies, breech presentation 
was associated with advanced maternal age, nulliparity, 
maternal hypothyroidism, pre-gestational diabetes, pla-
centa praevia, PROM, oligohydramnios, fetal congenital 
anomaly, female sex of the fetus, and birth weight below 
the tenth percentile. A previous cesarean section is known to 
be positively related to the odds of having a fetus in breech 
presentation at term [5, 14], and in our study, this risk factor 
started to show already in moderate to late preterm pregnan-
cies. Instead of the scar being the cause of breech presen-
tation, it is more likely that the women with a history of 
breech cesarean section have, during subsequent pregnan-
cies, a fetus in breech presentation again or have a cesarean 
section for another reason [3, 5, 37]. Our data suggest that 
the advanced maternal age and nulliparity are the risks for 
breech presentation at term, but as well as in moderate to 
late preterm pregnancies. The tight wall of the abdomen and 
the uterus of nulliparous women might inhibit the fetus from 
rotating to cephalic presentation [9]. In a meta-analysis from 
2017, older maternal age has been considered to increase the 
risk of placental dysfunction such as pre-eclampsia and pre-
term birth [36] that are also common risk factors for breech 
presentation [4, 5]. Bearing the first child in older maternal 
age and giving birth by cesarean section may affect the deci-
sion not to have another child and might explain the higher 
rate of nulliparity among moderate to late preterm and term 
deliveries [1]. Our study found correlation between mater-
nal hypothyroidism and breech presentation at term. Some 
studies have demonstrated an association between maternal 
thyroid hypofunction and adverse pregnancy outcomes such 
as pre-eclampsia and low birth weight which are, further-
more, risks for breech presentation and may explain partly 
the higher prevalence of maternal hypothyroidism in term 
breech deliveries [38–40]. However, the absence of screen-
ing of, for example, thyroid diseases may cause bias in the 
diagnoses.
Our study demonstrated that as gestation proceeds, more 
obstetric risk factors can be found associating with breech 
presentation. In the earlier gestation and excluding PPROM, 
breech deliveries did not differ in obstetric risk factors com-
pared to cephalic. The risk factors in 32 weeks of gestational 
age are comparable to those in term pregnancy, and sev-
eral of these factors, such as low birth weight, congenital 
anomalies and history of cesarean section, are associated 
Table 3  Unadjusted and adjusted odds ratios for risk factors in singleton moderate to late preterm 32 + 0 to 36 + 6  weeks of gestational age 
fetuses in breech and in cephalic presentations during 2004–2014 in Finland
BMI body mass index, IVF in vitro fertilization, PPROM preterm premature rupture of membranes
32–36 Weeks of gestation Breech (N = 1854) Cephalic (N = 24 997) P value Odds ratio (95% Cl) Adjusted odds 
ratio (95% CI)
Maternal age < 25 39 (2.1%) 741 (3.0%) 0.020 0.70 (0.51–0.97) 0.68 (0.48–0.94)
Maternal age ≥ 35 451 (24.3%) 5409 (21.6%)  < 0.001 1.16 (1.04–1.30) 1.24 (1.10–1.39)
Smoking 293 (15.8%) 4426 (17.7%) 0.139 0.87 (0.77–0.99) 0.91 (0.79–1.03)
Maternal BMI ≥ 25 202 (10.9%) 3359 (13.4%) 0.004 0.79 (0.68–0.92) 0.75 (0.62–0.91)
Maternal BMI ≥ 30 80 (4.3%) 1175 (4.7%) 0.120 0.91 (0.73–1.15) 1.26 (0.94–1.69)
Nulliparity 1048 (56.5%) 12,235 (48.9%)  < 0.001 1.36 (1.23–1.49) 1.43 (1.27–1.60)
Parity ≥ 3 158 (8.5%) 2665 (10.7%) 0.134 0.78 (0.66–0.92) 0.87 (0.73–1.04)
Maternal hypothyroidism 21 (1.1%) 259 (1.0%) 0.360 1.09 (0.70–1.71) 1.24 (0.78–1.96)
Maternal hyperthyroidism 6 (0.3%) 48 (0.2%) 0.100 1.69 (0.72–3.95) 2.06 (0.87–4.87)
Pre-gestational diabetes treated with insulin 5 (0.3%) 118 (0.5%) 0.066 0.57 (0.23–1.40) 0.76 (0.57–1.02)
Gestational diabetes 159 (8.6%) 2481 (9.9%) 0.099 0.85 (0.72–1.01) 0.86 (0.72–1.03)
Pre-eclampsia/hypertension 161 (8.7%) 2232 (8.9%) 0.394 0.97 (0.82–1.15) 0.93 (0.78–1.10)
Previous cesarean section 255 (13.8%) 3423 (13.7%)  < 0.001 1.01 (0.88–1.15) 1.31 (1.12–1.53)
IVF 75 (4.0%) 900 (3.6%) 0.854 1.13 (0.89–1.44) 0.98 (0.76–1.25)
Maternal care for (suspected) damage to 
fetus by alcohol/drugs
3 (0.2%) 39 (0.2%) 0.760 1.04 (0.32–3.36) 0.83 (0.25–2.76)
Placenta praevia 36 (1.9%) 624 (2.5%) 0.240 0.77 (0.55–1.09) 0.81 (0.58–1.15)
Placental abruption 27 (1.5%) 414 (1.7%) 0.763 0.88 (0.59–1.30) 0.94 (0.63–1.40)
PPROM 437 (23.6%) 3968 (15.9%)  < 0.001 1.63 (1.46–1.83) 1.58 (1.41–1.78)
Oligohydramnios 55 (3.0%) 191 (0.8%)  < 0.001 3.97 (2.93–5.38) 3.60 (2.63–4.92)
Congenital anomaly 362 (19.5%) 3690 (14.8%)  < 0.001 1.40 (1.24–1.58) 1.37 (1.22–1.55)
Female sex 890 (48.0%) 10,817 (43.3%)  < 0.001 1.21 (1.10–1.33) 1.22 (1.11–1.34)
Birthweight < 10th percentile 205 (11.1%) 2012 (8.0%) 0.003 1.42 (1.22–1.65) 1.31 (1.10–1.56)
Birthweight > 97th percentile 41 (2.2%) 1162 (4.6%) 0.004 0.46 (0.34–0.64) 0.60 (0.42–0.85)
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with adverse fetal outcomes [1, 4, 5, 8, 14, 17] and must be 
taken into account when treating breech pregnancies. Risk 
factors should be evaluated prior to offering a patient an 
external cephalic version, as the presence of some of these 
risks may increase the change of failed version or fetal intol-
erance of the procedure. This study had adequate power to 
show differences between the risk profiles of breech and 
cephalic presentations in different gestational phase. Further 
research, however, is needed for improving the identification 
of patients at risk for preterm breech labor and elucidating 
the optimal route for delivery in preterm breech pregnancies.
Our study is unique since it is the first study, to our 
knowledge, that compares the risks for breech presentation 
in preterm and term deliveries. The analysis is based on a 
large nationwide population, which is the major strength of 
our study. The study population included nearly 34,000 pre-
term births over 11 years in Finland and 737,788 deliveries 
overall. The medical treatment of pregnancies is homog-
enous, since there are no private hospitals treating deliver-
ies. A further strength relates to the important information 
on the characteristics of the mother, for example smoking 
during pregnancy and pre-pregnancy body mass index. The 
retrospective approach is a limitation of the study, another 
one is the design as a record linkage study, due to which the 
variables were restricted to the data availability. Therefore, 
we were not able to assess, for example uterine anomalies 
or previous breech deliveries to the analysis.
Conclusion
Our results show that the factors associated with breech 
presentation in very late preterm breech deliveries resem-
ble those in term pregnancies. However, breech presenta-
tion in extremely preterm breech birth has similar clinical 
risk profiles as in cephalic presentation.
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Table 4  Unadjusted and adjusted odds ratios for risk factors in singleton term pregnancies in breech and in cephalic presentations during 2004–
2014 in Finland
BMI body mass index, IVF in vitro fertilization, PROM premature rupture of membranes
 ≥ 37 Weeks of gestation Breech (N = 17 044) Cephalic (N = 687 255) P value Odds ratio (95% Cl) Adjusted odds 
ratio (95% CI)
Maternal age < 25 304 (1.8%) 15,496 (2.3%)  < 0.001 0.79 (0.70–0.88) 0.57 (0.51–0.64)
Maternal age ≥ 35 3313 (19.4%) 130,687 (19.0%)  < 0.001 1.03 (0.99–1.07) 1.24 (1.19–1.29)
Smoking 2593 (15.2%) 102,333 (14.9%) 0.845 1.03 (0.98–1.07) 1.00 (0.95–1.04)
Maternal BMI ≥ 25 1753 (10.3%) 79,114 (11.5%)  < 0.001 0.88 (0.84–0.93) 0.90 (0.85–0.96)
Maternal BMI ≥ 30 588 (3.4%) 25,854 (3.8%) 0.56 0.91 (0.84–0.99) 1.03 (0.93–1.14)
Nulliparity 10,387 (60.9%) 281,094 (40.9%)  < 0.001 2.25 (2.19–2.33) 2.46 (2.37–2.55)
Parity ≥ 3 910 (5.3%) 68,532 (10.0%)  < 0.001 0.51 (0.48–0.54) 0.75 (0.70–0.81)
Maternal hypothyroidism 131 (0.8%) 3146 (0.5%)  < 0.001 1.68 (1.41–2.01) 1.53 (1.28–1.82)
Maternal hyperthyroidism 22 (0.1%) 634 (0.1%) 0.082 1.40 (0.91–2.14) 1.46 (0.95–2.24)
Pre-gestational diabetes treated with insulin 24 (0.1%) 789 (0.1%) 0.049 1.23 (0.82–1.84) 1.24 (1.00–1.53)
Gestational diabetes 1447 (8.5%) 57,613 (8.4%) 0.418 1.01 (0.96–1.07) 1.02 (0.97–1.08)
Pre-eclampsia/hypertension 600 (3.5%) 21,627 (3.1%) 0.07 1.12 (1.03–1.22) 0.93 (0.85–1.01)
Previous cesarean section 1847 (10.8%) 73,575 (10.7%)  < 0.001 1.01 (0.97–1.06) 1.67 (1.58–1.76)
IVF 483 (2.8%) 14,393 (2.1%) 0.68 1.36 (1.24–1.49) 0.98 (0.89–1.08)
Maternal care for (suspected) damage to 
fetus by alcohol/drugs
6 (0.0%) 734 (0.1%) 0.001 0.33 (0.15–0.74) 0.27 (0.12–0.60)
Placenta praevia 55 (0.3%) 1418 (0.2%) 0.007 1.57 (1.20–2.05) 1.45 (1.11–1.91)
Placental abruption 23 (0.1%) 995 (0.1%) 0.496 0.93 (0.62–1.41) 0.87 (0.75–1.31)
PROM 582 (3.4%) 12,938 (1.9%)  < 0.001 1.84 (1.69–2.01) 1.58 (1.45–1.72)
Oligohydramnios 453 (2.7%) 7867 (1.1%)  < 0.001 2.36 (2.14–2.60) 2.02 (1.83–2.22)
Congenital anomaly 2846 (16.7%) 62 002 (9.0%)  < 0.001 2.02 (1.94–2.11) 1.97 (1.89–2.06)
Female sex 9321 (54.7%) 336,313 (48.9%)  < 0.001 1.26 (1.22–1.30) 1.28 (1.24–1.32)
Birthweight < tenthth percentile 2153 (12.6%) 63,826 (9.3%)  < 0.001 1.41 (1.35–1.48) 1.18 (1.12–1.24)
Birthweight > 97th percentile 237 (1.4%) 15,679 (2.3%)  < 0.001 0.60 (0.53–0.69) 0.75 (0.65–0.85)
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